Anti-Insulin receptor (INSR) Monoclonal Antibody (Clone 18-44)

Anti-Insulin receptor (INSR) Monoclonal Antibody (Clone 18-44)

Product No.: 50104

- -
- -
Clone
18-44
Target
Insulin receptor (α subunit)
Formats AvailableView All
Product Type
Monoclonal
Alternate Names
IR, EC 2.7.10.1, CD antigen CD220 [Cleaved into: Insulin receptor subunitα; Insulin receptor subunit β]
Isotype
Mouse IgG2b
Applications
Act
,
IP
,
WB
,
Inhibitor
,
Stimulation

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Mouse
Immunogen
Human placental insulin receptor
Product Concentration
Lot Specific
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
State of Matter
Liquid
Product Preparation
Purified by Protein G affinity chromatography
Storage and Handling
This monoclonal antibody is stable for at least one (1) year at -20°C to -70°C. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles.
Country of Origin
USA
Shipping
Next Day 2-8°C
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Clone 18-44 a monoclonal antibody is specific to human insulin receptor; low-level cross-reactivity with bovine and rabbit samples. and rabbit insulin receptor.
Background
The insulin receptor (INSR) is a crucial receptor tyrosine kinase (RTK) that plays a central role in regulating glucose uptake in the body. When insulin binds to the extracellular domain of the INSR, it triggers a cascade of events leading to the absorption of glucose by cells.

The INSR shares significant structural and functional similarities with the IGF-1 receptor (IGF-1R), highlighting their related roles in cellular signaling. One of the earliest cellular responses to insulin stimulation is the autophosphorylation of tyrosine residues within the INSR, a critical step in initiating the downstream signaling pathways.

In humans, the gene encoding the INSR is located on chromosome 19. Dysfunctions or defects in the INSR can lead to a range of insulin resistance syndromes, impacting the body's ability to respond effectively to insulin. Similarly, defects in the IGF-1R can contribute to certain forms of growth retardation.
Function
Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically rUniProtKB:P15208, PubMed:12138094, PubMed:16314505, PubMed:16831875, PubMed:8257688, PubMed:8276809, PubMed:8452530, PubMed:9428692}.
NCBI Gene Bank ID
UniProt.org
Research Area
Growth Factors, Cytokines, Receptors

References & Citations

Soos et al. (1986) Biochem J 235: 199.
Brindle et al. (1990) Biochem J 268: 615.
Prigent et al. (1990) J Biol Chem 265: 9970
Act
Immunoprecipitation Protocol
General Western Blot Protocol
Inhibitor
Stimulation

Certificate of Analysis

Formats Available

Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.